Agloe Medical is a technology company.
Agloe Medical has raised $15.0M across 1 funding round.
Agloe Medical has raised $15.0M in total across 1 funding round.
Agloe Medical has raised $15.0M in total across 1 funding round.
Agloe Medical's investors include Qiming Venture Partners, RA Capital.
Agloe Medical is a family-owned technology company specializing in the development and manufacturing of patient monitoring devices and telemetry systems designed to improve patient safety and outcomes. Their product line includes premium measurement modules and accessories used in clinical settings, emphasizing innovation and high-quality standards to meet healthcare providers' needs. Agloe Medical serves hospitals, clinics, and healthcare professionals by providing reliable medical devices that address the critical problem of accurate patient monitoring, which is essential for timely clinical decisions and patient care. The company prioritizes customer satisfaction and long-term relationships, reflecting steady growth through a commitment to quality and service[2].
Agloe Medical Devices LLC was founded as a family-operated business, fostering a close-knit work environment where employees are treated like family. This culture supports cohesive teamwork focused on delivering the best patient-side products. The company's founding story centers on a dedication to patient safety and innovation, with years of research backing their product development. While specific founding year and founders' details are not publicly highlighted, the company’s evolution reflects a deep commitment to healthcare technology and customer service, which has been pivotal in establishing early trust and traction within the medical device market[2].
Agloe Medical operates within the growing healthcare technology sector, particularly in medical device innovation focused on patient monitoring. The timing is critical as healthcare systems worldwide increasingly adopt digital and connected health solutions to improve patient outcomes and operational efficiency. Trends such as remote patient monitoring, telehealth expansion, and data-driven clinical decision-making create favorable market conditions for companies like Agloe Medical. By providing reliable and innovative monitoring technologies, Agloe Medical contributes to enhancing clinical workflows and patient safety, influencing the broader ecosystem of healthcare delivery and medical technology advancement[2].
Looking ahead, Agloe Medical is well-positioned to capitalize on the increasing demand for advanced patient monitoring solutions driven by healthcare digitization and an aging global population. Continued innovation in telemetry and integration with digital health platforms could further accelerate their growth. Trends such as AI-assisted monitoring and interoperability with electronic health records may shape their product development roadmap. As healthcare providers seek more reliable and user-friendly monitoring systems, Agloe Medical’s commitment to quality and patient safety will likely strengthen its market position and influence in the medical device industry[2].
Agloe Medical has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $15.0M Series A | Qiming Venture Partners, RA Capital |